Clinical Trials Logo

Urinary Bladder Neck Obstruction clinical trials

View clinical trials related to Urinary Bladder Neck Obstruction.

Filter by:

NCT ID: NCT00710749 Completed - Clinical trials for Lower Urinary Tract Symptoms

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Start date: July 2008
Phase: N/A
Study type: Interventional

Crossover comparison of different flow meters with a digital home flow meter as a reference. Main hypothesis: Reapeated home flow measurements with a disposable device will provide a better understanding of the patients urinary flow than a single measurement performed in the clinic.

NCT ID: NCT00696761 Completed - BPH Clinical Trials

The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients

Start date: May 2006
Phase: Phase 4
Study type: Interventional

Benign prostatic hyperplasia (BPH) is a common condition among older men. The efficacy of α1-blockers for treating BPH has been well documented and they are recommended for the treatment of BPH by clinical guidelines. It is not well known if a stratification based on the grade of BOO and bladder contractility has any predictive value for patients who are treated with an α1-selective blocking agent. In our study, we investigated possible differences in treatment outcome between patients with and without BOO, and with or without proper contractility who are treated with alfuzosin. So we will compare the quantified improvements 12 months after alfuzosin medication in LUTS/BPH patients by the grade of BOO and/or bladder contractility.

NCT ID: NCT00605319 Completed - Clinical trials for Bladder Outlet Obstruction

An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia

Toviaz
Start date: January 2010
Phase: Phase 4
Study type: Interventional

The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.

NCT ID: NCT00507455 Completed - Clinical trials for Lower Urinary Tract Symptoms

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Start date: June 2007
Phase: Phase 2
Study type: Interventional

A study to evaluate the safety of the co-administration of solifenacin succinate with tamsulosin hydrochloride in men with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO).

NCT ID: NCT00410514 Completed - Clinical trials for Lower Urinary Tract Symptoms

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Start date: December 2006
Phase: Phase 2
Study type: Interventional

This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.

NCT ID: NCT00252941 Completed - Prostate Cancer Clinical Trials

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Start date: November 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the feasibility, safety, and efficacy of the Memokath® 028SW stent to prevent urinary obstructive symptoms (difficulty urinating) when used after prostate seed implantation for the treatment of localized prostate cancer.

NCT ID: NCT00147654 Completed - Clinical trials for Urinary Incontinence

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Start date: November 2004
Phase: Phase 4
Study type: Interventional

The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).